Biggest News Aggregation in the World

Accelerated Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerated Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerated Approval Today - Breaking & Trending Today

Biogen Inc.: FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Published: June 10, 2024

TOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts

Source: finanznachrichten.de

VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients

Published: May 29, 2024

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response and two stable disease observations have occurred as of May 15,...

Source: marketscreener.com

FDA Issues New Draft Guidances On Cancer Clinical Trial Eligibility Criteria

Published: May 28, 2024

Understand the latest FDA guidance on cancer clinical trials with summary and content from Marjorie Zettler, Ph.D., MPH.

Source: clinicalleader.com

Biogen: LEQEMBI Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea

Published: May 28, 2024

TOKYO and CAMBRIDGE, Mass., May 28, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved humanized anti-soluble

Source: finanznachrichten.de

Biogen : "LEQEMBI®" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea

Published: May 27, 2024

TOKYO and CAMBRIDGE, Mass., May 27, 2024 - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food and Drug Safety in South Korea has approved humanized...